https://prabadinews.com/
  • October 9, 2026
  • Last Update July 17, 2026 9:28 pm
  • United States of America

FDA approves new treatment for acromegaly, a rare endocrine disorder

FDA approves new treatment for acromegaly, a rare endocrine disorder

The U.S. Food and Drug Administration (FDA) approved Palsonify (paltusotine) tablets to treat adults with acromegaly who have had an inadequate response to surgery and/or for whom surgery is not an option.

administrator

Related Articles